Efficacy and safety of granulocyte, monocyte/macrophage adsorptive in pediatric ulcerative colitis

doi:10.3748/wjg.v22.i17.4389

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 17

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7599)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-8) series.

Item

Count

PDF

473

WORD

213

HTML

2962

Figures (1-3)

127

Tables (1-8)

128

Sum=3903

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1221

Download

2475

Sum=3696

May 7, 2016 (publication date) through Apr 23, 2024

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trials Study

World J Gastroenterol. May 7, 2016; 22(17): 4389-4396
Published online May 7, 2016. doi: 10.3748/wjg.v22.i17.4389

Table 3 Categories of pediatric ulcerative colitis activity index changes at week 12

Significant improvement	≥ 35
Moderate improvement	≥ 20
Small improvement	≥ 10
No change	< 10

Citation: Ruuska T, Küster P, Grahnquist L, Lindgren F, Wewer AV. Efficacy and safety of granulocyte, monocyte/macrophage adsorptive in pediatric ulcerative colitis. World J Gastroenterol 2016; 22(17): 4389-4396
URL: https://www.wjgnet.com/1007-9327/full/v22/i17/4389.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i17.4389